miR-21 |
M2 |
SIRPb1 |
Promotes M2 polarization, downstream of CSF-1R |
[42] |
|
miR-21 |
M1 |
STAT3 |
Prevents PGE2-Mediated M2 polarization |
[43] |
|
miR-9 |
M1 |
PPAR-δ |
Suppresses anti-inflammatory response |
[45] |
|
miR-127 |
M1 |
Bcl6 |
Promotes M1 phenotype through activation of JNK pathway |
[46] |
|
miR-155 |
M1 |
???? |
Promotes pro-inflammatory responses via JNK pathway |
[47] |
C/EBPβ |
Inhibits M2 polarization |
[49] |
SOCS1 |
Promotes pro-inflammatory responses via P13K/Akt1 pathway |
[50] |
|
miR-125b |
M1 |
IRF4 |
Enhances pro-inflammatory responses |
[51] |
|
miR-124 |
M2 |
STAT3, TACE |
Inhibits production of pro-inflammatory cytokines |
[52] |
|
miR-223 |
M2 |
STAT3 |
Promotes anti-inflammatory response |
[54] |
|
miR-34a |
M2 |
Notch1 |
Inhibits production of pro-inflammatory cytokines |
[56] |
|
Let-7c |
M2 |
PAK1 |
Inhibits activation of NF-κB pathway |
[57] |
C/EBP-δ |
Promotes M2 phenotype |
[58] |
|
miR-132 |
M2 |
AChE |
Promotes cholinergic anti-inflammatory response |
[59] |
|
miR-146a |
M2 |
IRAK1,TRAF6 |
Prevents activation of NF-κB |
[61] |
|
miR-125a-5p |
M2 |
KLF4 |
Promotes M2 polarization |
[62] |